iThera Medical awarded major European grant to translate its optoacoustic imaging technology from research to routine clinical use
Munich, DE – Medical device company iThera Medical announces successful funding of the Horizon Europe technology innovation project FRONTIER. Under the EIC Accelerator program, Europe’s largest and most selective public funding program for breakthrough innovation projects, the EU will provide €2.5 million grant funding and up to €15 million equity. Through this project, iThera Medical […]
Dr. Ruiqing Ni, group leader at the Institute for Regenerative Medicine, UZH and Institute for Biomedical Engineering, ETH
Imaging device company iThera Medical announces the launch of its new inVision TRIO preclinical optoacoustic imaging system. The inVision TRIO is the first imaging system in the world that incorporates transmission ultrasound computed tomography (TUCT) and expands the field of biomedical applications addressable using iThera Medical’s optoacoustic imaging systems. As the world leader in optoacoustic […]
iThera Medical reports initiation of second site in ongoing clinical study for the non-invasive assessment of inflammatory bowel disease
Medical device company iThera Medical announces that the second site in Germany has been initiated for the ongoing clinical study in the EU-funded Horizon 2020 project EUPHORIA. The project aims to further develop the company’s proprietary optoacoustic imaging technology and demonstrate its clinical value in the assessment of inflammatory bowel disease (IBD). The chronic condition […]
iThera Medical leads €1.9m research project to advance optoacoustic imaging technology towards AI-supported quantitative medical diagnosis
Medical device company iThera Medical announces the kickoff of the Bavarian state-funded technology innovation project DeepOPUS. The project aims to augment the company’s proprietary optoacoustic imaging technology using AI technology, developing it into a quantitative diagnostic method for inflammatory bowel disease (IBD) and beyond. Multispectral optoacoustic tomography (MSOT) is an innovative, non-invasive diagnostic imaging method […]
The Munich-based biomedical imaging company was awarded the CE Mark for its MSOT Acuity Echo imaging system, indicating conformity with health, safety and environmental protection for medical devices sold in Europe. Following the first CE mark for its optoacoustic imaging system MSOT Acuity in 2019, this newly CE-marked device now combines optoacoustic with ultrasound tomography. […]
Emily L. Geisler, medical student at the Wertheim College of Medicine, FL, USA.
Dr. Katja Haedicke from iThera Medical, Dr. Andrea Murray from University of Manchester, Dr. Dinish U.S and Dr. Amalina Binte Ebrahim Attia from A*STAR Singapore Bioimaging Consortium and Dr. Juan Aguirre from Technical University Munich.
Prof. Dr. med. Maximilian Waldner, Professor of Functional Imaging in Medicine at the University Hospital Erlangen
Dr André Stiel, group leader at the Institute of Biological Medical Imaging at the Helmholtz Zentrum in Munich